Life Sciences Research Inc - Amended Statement of Beneficial Ownership (SC 13D/A)
20 Dezembro 2007 - 1:45PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2)(1)
Life Sciences Research, Inc.
(Name of Issuer)
Voting Common Stock, $.01 par value
(Title of Class of Securities)
5321691090
(CUSIP Number)
Brian Cass
c/o Life Sciences Research, Inc.
Woolley Road
Alconbury, Huntingdon
Cambridgeshire PE28 4HS
United Kingdom
+44 (0) 1480 892 000
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
December 18, 2007
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7(b)
for other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of Pages)
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
(SC13D-07/99)
CUSIP No.5321691090 13D Page___ of __ Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Brian Cass
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [x]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
Not Applicable
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
Not applicable
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
________________________________________________________________________________
7 SOLE VOTING POWER 711,393
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER 0
BENEFICIALLY
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER 711,393
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER 0
WITH
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
711,393
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
Not applicable [_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.5%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
CUSIP No.5321691090 13D Page___ of __ Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Brian Cass Private Pension Plan
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [x]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
Not Applicable
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
Not applicable
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United Kingdom
________________________________________________________________________________
7 SOLE VOTING POWER 0
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER 0
BENEFICIALLY
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER 0
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER 0
WITH
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
48,243
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
Not applicable [_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Less than 1%.
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
EP
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
|
CUSIP No. 13D Page of Pages
________________________________________________________________________________
Item 1. Security and Issuer.
Class of Securities: Voting Common Stock, $.01 par value per share
(the "Common Stock")
Issuer: Life Sciences Research, Inc. (the "Issuer"), P.O. Box 2360,
Mettlers Road, East Millstone, NJ 08875
________________________________________________________________________________
Item 2. Identity and Background.
(a) Name: Brian Cass
(b) Business Address: Brian Cass
c/o Life Sciences Research, Inc.
Woolley Road
Alconbury, Huntingdon
Cambridgeshire PE28 4HS
United Kingdom
(c) Principal Occupation or Employment:
President of the Issuer.
(d) Criminal Convictions: None.
(e) Civil Adjudication of Violation of Securities Laws: None.
(f) Citizenship: United Kingdom citizen.
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
Not applicable
________________________________________________________________________________
Item 4. Purpose of Transaction.
(a)-(j) This filing is made to report the transfer by Mr. Cass into his
personal pension plan on December 18, 2007 of 16,750 shares of Common Stock.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
(a) Beneficial Ownership by the Reporting Person:
Number of Shares
----------------
Aggregate number of shares: 711,393
Percentage: 5.5%(based on 12,623,348 outstanding
shares of common stock as of
10/29/07 as reported in the
Issuer's Form 10-Q for the
Quarter ended September 30, 2007
plus 255,500 shares subject to
presently exercisable options
held by Mr.Cass being deemed
outstanding)
(b) Sole Voting Power: 711,393
Shared Voting Power: 0
Sole Dispositive Power: 711,393
Shares Dispositive Power: 0
(c) Mr. Cass transferred 16,750 shares of Common Stock into his personal
pension plan.
(d) Not applicable.
(e) Not applicable.
________________________________________________________________________________
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
Not applicable.
________________________________________________________________________________
Item 7. Material to be Filed as Exhibits.
None.
________________________________________________________________________________
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
December 20, 2007
(Date)
/s/ Brian Cass
----------------------------------------
(Signature)
|
Brian Cass
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
EDGARLink 7.0 (8/00) Ver. 3.1
Life Sciences Research (NYSE:LSR)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Life Sciences Research (NYSE:LSR)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
